Close

Anti-CD34 DNA-encoded mAb (DMAb), pVAX1 (DMAb-1235-YY)


All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product is the plasmid containing an encoded anti-CD34 DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.

  Add to Cart

Specifications

  • Target
  • CD34
  • Vector Name
  • pVAX1
  • Vector Description
  • pVAX1 was originally designed for the development of DNA vaccines. Its eukaryotic DNA sequences limited to the expression of desired sequence so that minimize the possibility of chromosomal integration. This vector has been widely used for the construction of DMAb plasmid.
  • Vector Promoter
  • CMV
  • Vector Tag or Fusion
  • Untagged
  • Delivery Method
  • Transfection
  • Cloning Method
  • Restriction Enzyme ⁄ MCS
  • Constitutive or Inducible System
  • Constitutive
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term.
  • Background
  • DNA-encoded mAb (DMAb) technology is a novel approach for a direct in vivo production of desired biologically active immunoglobulins according to the plasmid DNA delivery into tissue where the delivered plasmid containing an encoded antibody sequence. Compared with the traditional mAb, DMAb can be functionally equivalent with additional advantages such as expression profiles, glycosylation, as well as no reliance on in vivo tissue culture and costly or time-consuming production systems. The DMAb technology may provide a novel, simple, less frequent, cost-effective approach for therapeutics.

Target

  • Entrez Gene ID
  • 947
Sub CAT. DMAb Clone DMAb Host Target Species DMAb Isotype DMAb Immunogen  
DMAb-1235-YY CBYY-C3231 Rabbit Human IgG Recombinant Human CD34 protein. This antibody was obtained from a rabbit immunized with purified, recombinant Human CD34
DMAb-1123-YY CBYY-C1323 Mouse Human IgG2b
DMAb-1124-YY CBYY-C1324 Mouse Human IgG2b
DMAb-1125-YY CBYY-C1325 Mouse Human IgG1 KG1 human acute myelogenous cells
DMAb-1126-YY CBYY-C1326 Mouse Human IgG2a
DMAb-1127-YY CBYY-C1327 Mouse CD34 (NP_001764, 32aa-141aa) partial recombinant protein with GST tag. MW of the GST tag alone is 26kD
DMAb-1128-YY CBYY-C1328 Mouse Human IgG1, κ
DMAb-1129-YY CBYY-C1329 Mouse Human IgG1 KG1 human acute myelogenous cells
DMAb-1130-YY CBYY-C1330 Mouse Human IgG1 Blast cells of a chronic myeloid leukemia patient
DMAb-1109-YY CBYY-C0709 Mouse Human IgG1, κ
DMAb-1106-YY CBYY-C0602 Mouse Human IgG3, κ Human KG-1a tumor cells
DMAb-1100-YY CBYY-C0559 Rat Mouse IgG2a Mouse myeloma cell line NS0-derived recombinant mouse CD34, Thr35-Thr287, Accession # Q64314
DMAb-1103-YY CBYY-C0568 Mouse Human IgG2b Partial recombinant human CD34 protein (aa32-290)
DMAb-1090-YY CBYY-C0390 Mouse Human IgG2b, κ Human CD34
DMAb-1083-YY CBYY-C0328 Mouse Human IgG2a, κ
DMAb-1084-YY CBYY-C0329 Mouse Human IgG1, κ
DMAb-1085-YY CBYY-C0346 Mouse Human IgG1 Human T lymphocytes
DMAb-0138-CN MEC14.7 Rat Mouse IgG2a, κ Full length protein corresponding to Mouse CD34. Murine transformed endothelioma cell line t-end

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-CD34 DNA-encoded mAb (DMAb), pVAX1 (DMAb-1235-YY). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.